The Food and Drug Administration is facing backlash over its approval of a genetic test intended to determine if a person is at increased risk for opioid addiction.
Related Posts
Michigan, the last state to still prohibit surrogacy contracts, ends its ban
Until Monday, Michigan was the only U.S.